Finance

Lists
VRCA:NASDAQ
Verrica Pharmaceuticals Inc
$ 4.14
-1.66%
(-0.070) 1D
$ 4.22
+1.93% (+0.080)
After hours
Closed: 10-р сарын 7, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRCA...
Open
$ 4.15
High
$ 4.33
Low
$ 4.06
Mkt. cap
71.12 сая
Avg. vol.
76.11 мян
Volume
47.65 мян
52-wk high
$ 9.82
52-wk low
$ 3.28
EPS
-$ 1.67
Beta
1.60
Shares outstanding
17.18 сая
No. of employees
76
Open
$ 4.15
High
$ 4.33
Low
$ 4.06
Mkt. cap
71.12 сая
Avg. vol.
76.11 мян
Volume
47.65 мян
52-wk high
$ 9.82
52-wk low
$ 3.28
EPS
-$ 1.67
Beta
1.60
Shares outstanding
17.18 сая
No. of employees
76
News stories
From web sources and news partners
About Verrica Pharmaceuticals Inc
CEOJayson Rieger
Employees76
Founded2013
HeadquartersWest Chester, Пеннсилвани, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to VRCA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VRCA in the last 3 months.
Highest
Current $ 4.14
$ 20.00 (+383.09%)
Average
$ 13.67 (+230.19%)
Lowest
$ 9.00 (+117.39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
$ 9.00
+117.4%
10/01/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/27/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$ 12.00
+189.9%
08/07/2026
Stacy Ku
TD Cowen
Buy
Reiterated
$ 20.00
+383.1%
08/06/2026
Kemp Dolliver
Brookline Capital Markets
Buy
Upgraded
$ 17.00
+310.6%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
14.34 сая
5.09 сая
5.02 сая
5.86 сая
Cost of goods sold
3.31 сая
3.92 сая
4.75 сая
6.91 сая
Cost of revenue
3.31 сая
3.92 сая
4.75 сая
6.91 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.40 сая
8.12 сая
9.99 сая
10.35 сая
Operating expense
9.40 сая
8.12 сая
9.99 сая
10.35 сая
Total operating expenses
12.72 сая
12.04 сая
14.74 сая
17.26 сая
Operating income
1.63 сая
-6.95 сая
-9.72 сая
-11.40 сая
Other non operating income
34.00 мян
1.76 сая
-8.00 мян
-3.00 мян
EBT including unusual items
-274.00 мян
-8.07 сая
-9.68 сая
-13.15 сая
EBT excluding unusual items
-274.00 мян
-6.30 сая
-9.68 сая
-11.46 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-274.00 мян
-8.07 сая
-9.68 сая
-13.15 сая
Net profit margin
-1.91%
-158.56%
-192.75%
-224.38%
Earnings per share
0.13
-0.51
-0.45
-0.48
Interest and investment income
159.00 мян
205.00 мян
201.00 мян
111.00 мян
Interest expense
-2.09 сая
-1.31 сая
-160.00 мян
-164.00 мян
Net interest expenses
-1.94 сая
-1.11 сая
41.00 мян
-53.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
1.74 сая
-6.83 сая
-9.60 сая
-11.27 сая
Gain or loss from assets sale
68.00 мян
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс